PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,355 | -18.8% | 15,136 | +3.0% | 0.00% | – |
| Q2 2023 | $192,612 | +30.1% | 14,692 | +10.9% | 0.00% | – |
| Q1 2023 | $148,101 | +32.6% | 13,247 | 0.0% | 0.00% | – |
| Q4 2022 | $111,672 | -49.4% | 13,247 | 0.0% | 0.00% | – |
| Q3 2022 | $220,695 | +20.6% | 13,247 | +6.7% | 0.00% | – |
| Q2 2022 | $183,000 | -30.9% | 12,420 | +16.5% | 0.00% | -100.0% |
| Q1 2022 | $265,000 | -20.9% | 10,662 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $335,000 | -9.7% | 10,440 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $371,000 | -15.1% | 10,325 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $437,000 | +84.4% | 9,897 | +91.1% | 0.00% | – |
| Q1 2021 | $237,000 | -10.9% | 5,178 | +34.5% | 0.00% | -100.0% |
| Q4 2020 | $266,000 | – | 3,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |